Log In
BCIQ
Print this Print this
 

NP002

  Manage Alerts
Collapse Summary General Information
Company Neuraltus Pharmaceuticals Inc.
DescriptionSmall molecule oral nicotinic receptor agonist
Molecular Target Nicotinic receptor
Mechanism of ActionNicotinic receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationHyperkinetic movement disorder
Indication DetailsTreat levodopa-induced dyskinesias in patients with Parkinson's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today